Abiraterone acetate (Zytiga)
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Abiraterone acetate (Zytiga), covering 2013-04-12 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer [Phase 2]